PMID- 35844687 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220719 IS - 2688-6146 (Electronic) IS - 2688-6146 (Linking) VI - 2 IP - 3 DP - 2021 Aug TI - Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysis. PG - 466-470 LID - 10.1002/jha2.211 [doi] AB - Intravenous immunoglobulin (IVIG) and therapeutic plasma exchange (TPE) are used in select cases with heparin-induced thrombocytopenia (HIT). In a cross-sectional analysis, a propensity matched sample was generated by IVIG or TPE treatment status to assess the primary outcome of mortality. In 500 HIT cases, IVIG or TPE was not associated with increased mortality (OR = 1.46; 95% CI: 0.81-2.63, p = 0.2052) but was associated with a higher likelihood of major bleeding (OR = 1.75; 95% CI: 1.03-2.96, p = 0.0376). The use of IVIG or TPE in HIT cases with bleeding contraindications to standard therapies should be further investigated. CI - (c) 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. FAU - Soares Ferreira Junior, Alexandre AU - Soares Ferreira Junior A AD - School of Medicine Barretos School of Health Sciences Dr. Paulo Prata Barretos Sao Paulo Brazil. AD - Department of Medicine Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP) Sao Jose do Rio Preto Sao Paulo Brazil. FAU - Boyle, Stephen H AU - Boyle SH AD - Duke University School of Medicine Durham North Carolina USA. FAU - Kuchibhatla, Maragatha AU - Kuchibhatla M AD - Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina USA. FAU - Onwuemene, Oluwatoyosi A AU - Onwuemene OA AUID- ORCID: 0000-0001-7266-7101 AD - Division of Hematology Department of Medicine Duke University School of Medicine Durham North Carolina USA. LA - eng PT - Journal Article DEP - 20210507 PL - United States TA - EJHaem JT - EJHaem JID - 101761942 PMC - PMC9175867 OTO - NOTNLM OT - National Inpatient Sample OT - heparin-induced thrombocytopenia OT - intravenous immune globulin OT - therapeutic plasma exchange COIS- The authors declare no conflict of interest. EDAT- 2021/05/07 00:00 MHDA- 2021/05/07 00:01 PMCR- 2021/05/07 CRDT- 2022/07/18 03:40 PHST- 2021/03/30 00:00 [received] PHST- 2021/04/14 00:00 [revised] PHST- 2021/04/20 00:00 [accepted] PHST- 2022/07/18 03:40 [entrez] PHST- 2021/05/07 00:00 [pubmed] PHST- 2021/05/07 00:01 [medline] PHST- 2021/05/07 00:00 [pmc-release] AID - JHA2211 [pii] AID - 10.1002/jha2.211 [doi] PST - epublish SO - EJHaem. 2021 May 7;2(3):466-470. doi: 10.1002/jha2.211. eCollection 2021 Aug.